Pacira Pharmaceuticals reported $46.32M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US $ -8.38M 1.47M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Amerisourcebergen ABC:US $ 637.71M 60.52M
Antares Pharma ATRS:US $ 7.22M 1.66M
Astellas Pharma 4503:JP Y 53255M 17425M
Bristol Myers Squibb BMY:US $ 5289M 67M
Cara Therapeutics CARA:US $ -1013000 29.73M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Johnson & Johnson JNJ:US $ 8058M 282M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Omeros OMER:US $ -22703000 5.89M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Supernus Pharmaceuticals SUPN:US $ 28.96M 2.28M
Teva Pharmaceutical TEVA:IT 382M 412M
Xoma XOMA:US $ -4.44M 2.2M
Zoetis ZTS:US $ 717M 11M